EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Determining the time to cholangiocarcinoma in pediatric‐onset PSC‐IBD

Batul Kaj-Carbaidwala, Johan Fevery, Douglas G Adler, Annika Bergquist, Lissy de Ridder, Mark Deneau, Corinne Gower-Rousseau, Roger W Chapman, Kate D Lynch, Catherine A M Stedman, David C Wilson, Uzma Shah und 3 weitere

Journal of Pediatric Gastroenterology and Nutrition · 2025

DOI: 10.1002/jpn3.12443 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2025. Verfasst von Batul Kaj-Carbaidwala und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Gastroenterology, Hepatology and Nutrition, MassGeneral Hospital for Children, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Cholangitis, Sclerosing, Bile Duct Neoplasms, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: NIH HHS, The Hasso Serrano Foundation, Martin Schlaff.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary sclerosing cholangitis (PSC) is a risk factor for cholangiocarcinoma. When a child is diagnosed with both PSC and inflammatory bowel disease (IBD), evidence‐based information on counseling families and risk management of developing cholangiocarcinoma is limited. In this case series (PubMed/collaborators), we included patients with PSC‐IBD who developed cholangiocarcinoma and contacted authors to determine an event curve specifying the time between the second diagnosis (IBD or PSC) and a diagnosis of cholangiocarcinoma. Review of n = 175 studies resulted in a cohort of n = 21 patients with pediatric‐onset PSC‐IBD‐cholangiocarcinoma. The median time to development of cholangiocarcinoma was 6.95 years from the second diagnosis. Despite the small number, 38% of cholangiocarcinoma developed within the first 2 years, and 47% of patients developed cholangiocarcinoma in the transition period to adult care (age 14–25). Our findings highlight the importance of screening that extends over the so‐called transition period from pediatric to adult care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaCholangitis, SclerosingBile Duct NeoplasmsInflammatory Bowel DiseasesHumansAdolescentChildMaleFemaleRisk FactorsYoung AdultAdultTime FactorsAge of OnsetChild, Preschool

Stichwörter der Autor:innen

Crohn'spediatric cholangitisprimary sclerosing cholangitisulcerative colitis

Autor:innen und Institutionen

  • Division of Pediatric Gastroenterology, Hepatology and Nutrition, MassGeneral Hospital for Children, Boston, Massachusetts, USA.
  • Department of Hepatology, University Hospital Gasthuisberg, Leuven, Belgium.
  • Porter Adventist Hospital, Centura Health, Denver, Colorado, USA.
  • Division of Hepatology, Department of Upper GI Disease, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
  • Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Division of Pediatric Gastroenterology, Hepatology and Nutrition, University of Utah, Salt Lake City, Utah, USA.

ORCID-Profile: Harland S Winter

Förderung

  • NIH HHS
  • The Hasso Serrano Foundation
  • Martin Schlaff
  • Women's Wellness Foundation

Zitieren

APA

Kaj-Carbaidwala, B., Fevery, J., Adler, D. G., Bergquist, A., de Ridder, L., Deneau, M., Gower-Rousseau, C., Chapman, R. W., Lynch, K. D., Stedman, C. A. M., Wilson, D. C., Shah, U., Goyal, L., Winter, H. S., & Lennerz, J. K. (2025). Determining the time to cholangiocarcinoma in pediatric‐onset PSC‐IBD. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.12443

Vancouver

Kaj-Carbaidwala B, Fevery J, Adler DG, Bergquist A, de Ridder L, Deneau M, et al. Determining the time to cholangiocarcinoma in pediatric‐onset PSC‐IBD. Journal of Pediatric Gastroenterology and Nutrition. 2025. doi:10.1002/jpn3.12443

BibTeX
@article{KajCarbaidwala2025,
  author = {Kaj-Carbaidwala, Batul and Fevery, Johan and Adler, Douglas G and Bergquist, Annika and de Ridder, Lissy and Deneau, Mark and Gower-Rousseau, Corinne and Chapman, Roger W and Lynch, Kate D and Stedman, Catherine A M and Wilson, David C and Shah, Uzma and Goyal, Lipika and Winter, Harland S and Lennerz, Jochen K},
  title = {Determining the time to cholangiocarcinoma in pediatric‐onset PSC‐IBD},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2025},
  doi = {10.1002/jpn3.12443}
}
Kostenlos starten →